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Abstract
Background: Continuing comprehensive assessment of population health gap is essential for effective health
planning. This paper assessed changes in the magnitude and pattern of disease burden in Thailand between 1999
and 2004. It further drew lessons learned from applying the global burden of disease (GBD) methods to the Thai
context for other developing country settings.
Methods: Multiple sources of mortality and morbidity data for both years were assessed and used to estimate
Disability-Adjusted Life Years (DALYs) loss for 110 specific diseases and conditions relevant to the country’s health
problems. Causes of death from national vital registration were adjusted for misclassification from a verbal autopsy
study.
Results: Between 1999 and 2004, DALYs loss per 1,000 population in 2004 slightly decreased in men but a minor
increase in women was observed. HIV/AIDS maintained the highest burden for men in both 1999 and 2004 while
in 2004, stroke took over the 1999 first rank of HIV/AIDS in women. Among the top twenty diseases, there was a
slight increase of the proportion of non-communicable diseases and two out of three infectious diseases revealed
a decrease burden except for lower respiratory tract infections.
Conclusion: The study highlights unique pattern of disease burden in Thailand whereby epidemiological transition
have occurred as non-communicable diseases were on the rise but burden from HIV/AIDS resulting from the
epidemic in the 1990s remains high and injuries show negligent change. Lessons point that assessing DALY over
time critically requires continuing improvement in data sources particularly on cause of death statistics, institutional
capacity and long term commitments.
Background
Disability Adjusted Life Year (DALY) became widely
known in the 1993 when the World Bank introduced
this term in its report ‘Investing in Health’,a sas u m -
mary measure of population health for priority setting
[1]. DALY was recommended as an improved measure
because it combined fatal and non-fatal health out-
comes. It facilitates comparison of burden of diseases
(BOD) across different diseases and conditions and is
useful in measuring the magnitude and profile of BOD
either cross sectional or time trend comparisons, provid-
ing evidence for priority settings. It also forms basis for
selection of conditions and interventions for cost effec-
tiveness assessment [2-5].
Since the introduction of global estimates [6,7], there
had been a number of countries, mostly developed, con-
ducting national level BOD, for example, Australia, New
Zealand, USA and Mexico [8-11]. Some assessed BOD
on specific diseases, e.g. Korea and Sudan [12,13], or
sub-national level, for example, Switzerland and Taiwan
[14,15]. Some only estimated number of Year of Life
Loss (YLL) such as Burkina Faso due to lack of accurate
m o r b i d i t yd a t a[ 1 6 ] .N o n e t h e l e s s ,af e wd e v e l o p i n g
countries demonstrated capacities to sustain BOD
assessment though many studies were small scale assess-
ment or part of academic exercises [12,16,17]. BOD esti-
mations are far from complete around the world,
especially in developing countries.
Conducting BOD assessment requires tremendous
amount of epidemiological data. In developing countries,
mortality data are often not existing or incomplete;
causes of death are inaccurate; incidence and prevalence
* Correspondence: kanitta@ihpp.thaigov.net
1International Health Policy Program(IHPP), Ministry of Public Health,
Nonthaburi, Thailand
Bundhamcharoen et al. BMC Public Health 2011, 11:53
http://www.biomedcentral.com/1471-2458/11/53
© 2011 Bundhamcharoen et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.of illnesses are not routinely collected and accurately
reported. Duration of people living with disabilities in
each disease sequel is not possible without a cohort
study to monitor disease progression. All these posed
limits on BOD assessment in developing countries.
Clearly these demands for data require significant insti-
tutional capacity to establish and sustain vital registra-
tion and key morbidity reports, for which these
capacities were not fully developed or supported in
many country settings.
Thailand, a middle income country with reasonable
data collection system had been successful in producing
national level BOD assessment [18-20]. A crucial limita-
tion is a considerable proportion of mis-classification of
causes of death (COD) in vital registration. A study on
B O Di n1 9 9 6a d j u s t e dC O Df r o mv i t a lr e g i s t r a t i o nb y
modelling and squeeze algorithm [18]. In 1999 the first
nation-wide verbal autopsy (VA) study was initiated to
verify COD reported by vital registration [21]. Results
from this study provided essential information for the
1999 national level BOD assessment [19,20].
While the 1999 BOD study overcame limitation in
COD estimates, morbidity data on a small number of
diseases were assessed of poor quality [19]. In 2004,
based on improved morbidity data of certain diseases,
we updated and produced the 2004 national BOD.
This study assesses the national level BOD in Thailand
in1999 and 2004 with the application of the 1999 VA to
adjust COD in 1999 and 2004 and then compares them
in order to contribute to priority setting in health sector
investment and program reorientation. Furthermore,
this study draws lessons for other developing countries
in their efforts to conduct the national BOD assessment.
Methods
The study largely employed the methodology recom-
mended by the Global Burden Disease study (GBD) [22]
and the Australian burden of disease study [23] detailed
elsewhere. DALY is a sum of the years lost due to pre-
mature deaths (YLLs) and years lived with disability
condition (YLDs). YLLs were calculated with reference
to Coale and Demney model life table West Level 26
[24,25]. YLDs are summary of numbers of years in each
disabling conditions using disability weight (DW) to
represent severity of such conditions. See figure 1.
However, there were a number of modifications from
the GBD. First, disability weights (DW) were mostly
derived from the GBD with a few exceptions where the
Dutch weights were applied instead due to the fact that we
classified disease sequel according to the Australia’s study
which then used the Dutch weights. Second, we applied
similar discounting rate of 3% but chose not to apply the
age weights as in the GBD for the reason that children
and older people should not be valued less than adults.
Selection of causes, age group
GBD classified diseases into three levels of detail: group
I (infectious diseases, maternal, peri-natal and nutri-
tional disorders), group II (non-communicable diseases)
and group III (injuries). These three groups are further
divided into 22 subcategories and classified into more
specific conditions at level 3. We modified the lists of
disease classification in GBD to be more relevant to the
Thai epidemiology situation. Diseases deemed significant
to health policy, e.g. dengue and leptospirosis were
included in the list. As a result, 110 specific diseases
were finally selected. Ages were classified similar to
GBD classification (0-14, 15-29, 30-44, 45-59, 60-69,
70-79, 80+).
Mortality estimation
Mortality data were obtained from national vital regis-
tration. By Law, Thailand established civil registry sys-
tem where all births and deaths were mandatory
registered through a nation-wide coverage of civil regis-
tration system. Coverage of death registration improved
from 75-77% of total deaths in 1985-86 to 95% in
1995-96 according to the mid census Survey of Popula-
tion Change (SPC) conducted by National Statistical
Office [26]. We applied direct method technique for
adjusting the completeness of death registration, using
trend reported by the SPC [22,26,27].
COD estimates
Although coverage of death registry was high, COD was
assessed of low quality [28]. The 1999 VA study covered
DALY=YLL+YLD 
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Figure 1 Methodological framework.
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was conducted to a close relative of the total 43,790
deceased, COD was also verified with medical records in
hospitals in which the deceased had a record [21].
Assuming verified COD from VA study is accurate for
each COD certified by the official vital registration; cor-
recting factors were generated from the distribution of
verified causes in each cause assigned in official mortal-
ity records by age group, sex, and region [19]. For miss-
ing correction factors in some sub-groups, factors in the
wider groups were applied. For example, we divided age
into two classifications: 5-year categories (0, 1-4, 5-9, ...,
85+) and GBD larger age category, if there were no cor-
rection factors in the small age group, the relevant fac-
tors in larger age group were used instead.
Morbidity estimation
Data required for the YLD estimates consist of incidence,
duration of illness, or living with disability, and related
disability weights. Extensive reviews of local data sources
were performed to derive the best epidemiological esti-
mates. Sources of data included disease notification for
infectious diseases in the national epidemiological sur-
veillance system, health measurement survey for particu-
lar non-communicable diseases, household health
interview survey, hospital admission database, e.g. severe
injuries, and small scale survey for those diseases with no
other available data sources.
All data sources used in the study are not openly
available to the public. The data were obtained by for-
mal permission from respective data authorities. The
study was conducted under the supervision of the pro-
ject steering committee comprising major concerned
divisions in the Ministry of Public Health, and experts
from a number of Universities in Thailand.
Adjustment to account for coverage of individual data
sources was conducted. For example, hospitalization
data were extrapolated to compensate with coverage of
the data for different types of hospital. Diseases notifica-
tion data were adjusted for their non-reporting and
under coverage in particular from private sector. Valida-
tions of the data were undertaken by critical examining
the incidence and prevalence against values in other
countries and nearby regions. DisMod II [29], a software
application provided by WHO, was employed to check
internal consistency of parameters estimated. We pre-
sented sources of data, estimation approaches and
results to disease expert groups in a series of meetings
as external review processes.
Results
BOD in 2004
Total disease burden in 2004 amounts to 5.7 million
DALYs in men and 4.2 million DALYs in women. Fatal
burdens is the major component of BOD, it responsible
for 69% of total DALY loss in men and 62% in women.
Top twenty causes of DALYs loss accounted to 70 and
64 percent in men and women respectively. HIV/AIDS
was the leading cause of DALY and YLL in men, while
stroke caused the highest DALYs and YLL among
women. Traffic accidents and HIV/AIDS were the sec-
ond leading causes of DALY in men and women respec-
tively. Other conditions in the top five ranking were
stroke, alcohol dependence/harmful use, and liver cancer
in men; and HIV/AIDS, DM, and depression in women,
see Table 1.
BOD changes between 2004 and 1999
The total numbers of DALYs loss in 2004 were a little
higher than those in 1999 both in men and women.
Non-communicable diseases contributed to DALYs lar-
ger than group I (Communicable, nutritional, childhood
and maternal diseases) and group III (injuries). DALYs
loss from Group I decreased in 2004, mainly due to
reduction in HIV/AIDS deaths; an effect of implement-
ing universal access to ARV since 2002. Burden attribu-
ted to non-communicable disease (Group II) increased
largely due to demographic change. Burden from inju-
ries showed a negligible increase from 1999.
There was a slight decrease in the DALY loss per
1,000 population (so called DALY rate) among men,
from 187.6 in 1999 to 183.8 in 2004. In contrast, DALY
rate slightly increased among women, from 129.3 in
1999 to 132 in 2004. See Table 2 and 3. The proportion
of burden from premature deaths in 2004 decreased
among men, from 75% in 1999 to 69% in 2004, and
from 65% to 62% among women, indicating increasing
proportion of non fatality conditions for which people
lived in disabilities. Burden attributable to HIV/AIDS
considerably reduced from 32.3 to 21.1 DALYS per
1,000 population in men but moderately reduced in
women (12.2 to 9.3). Proportion of YLL to total DALY
due to HIV/AIDS in women slightly increased, but
opposite trend among men; this is likely reflecting
higher incidences in line with the projection showing
second wave of epidemic spread by sexual relation with
long-term female partners. Apart from non-fatal dis-
eases, DM, COPD, and Asthma had lower share of bur-
den from premature deaths ranging from 49 to 68 per
cent. Drowning and liver cancer had the highest share
of burden from premature deaths in men and women
respectively.
Among the top twenty leading causes of DALYs, it is
apparent that HIV/AIDS burden decreased both in men
and women. Only three communicable diseases were
listed in the top twenty. For men, only suicides and
homicide and violence demonstrated decreased burden
compared to 1999. For women, anaemia showed slightly
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road traffic injuries slightly increased in both men and
women. Burden from alcohol dependence/abuse, cirrho-
sis, and depression in men were much higher in 2004
than 1999; all the rest in the top ten causes in men had
moderate increasing trends. For women, HIV/AIDS
revealed a considerable decrease from 9% to 7% but not
as high as those found in men. Pattern of diseases in the
top ten groups in women were almost the same as it
was in 1999, only deafness took over cataract in 2004
where all other diseases remained in the top ten
although the ranks were slightly changed.
South East Asia Regional and Thailand estimates in 2004
The most recent 2004 BOD estimates by the WHO
grouped countries by WHO region and income per
capita, and by the World Bank geographical regions
used in the Disease Control Priorities Project (DCPP) in
which Thailand is low and middle income countries in
South East Asia region, and lower middle income coun-
tries in East Asia and Pacific region [30]. Compared to
our estimates, DALY rate in Thailand was far different
from that of South East Asia (SEA) region and more
close to the estimates for East Asia and Pacific (EAP) in
DCPP region, namely 265 and 271 in the SEA region
and 195 and 180 in the DCPP region for men and
women respectively (data not shown) while it was 184
and 132 DALY per 1000 population in men and women
in our estimate. For the WHO’s country estimates,
Thailand lost 232 and 180 DALY per 1,000 for men and
women respectively. These differences are partly due to
different method to adjust for incompleteness of vital
registration on death. In addition, some of morbidity
data were derived from different sources.
Disease burden pattern in Thailand is more similar to
upper middle income countries that HIV/AIDS showing
larger burden than diarrhoeal diseases and TB. Further-
more, HIV/AIDS was not found among the top ten causes
of burden in both SEA and EAP regions where Thailand
belongs to. Pattern of disease burden in Thailand inclined
towards non-communicable diseases, and ageing demo-
graphic compared with the SEA region.
Discussion
This study provided a comprehensive estimate of
national burden of disease in two periods using coun-
try best available data. The total DALY loss slightly
increased from 9.5 millions in 1999 to 9.9 million in
2004. However, the DALYs rate decreased in men but
increased in women. In 2004, two thirds of total
DALY loss was attributable to premature deaths.
Ratio of YLL to total DALYs in 2004 slightly
Table 1 Top twenty causes of DALY loss, 2004, Thailand
Top 20 ranking in men Death
(x1,000)
YLLs
(x1,000)
YLDs
(x1,000)
Top 20 ranking in women Death
(x1,000)
YLLs
(x1,000)
YLDs
(x1,000)
1. HIV/AIDS 26.4 634.2 17.7 Stroke 26.1 267.0 48.5
2. Traffic accidents 23.5 548.6 42.7 HIV/AIDS 11.0 279.5 15.1
3. Stroke 23.8 282.6 54.0 Diabetes 14.0 183.7 108.8
4. Alcohol dependence/
harmful use
1.0 18.1 315.2 Depression 0.0 0.0 191.5
5. Liver cancer 18.8 277.3 3.1 Ischaemic heart disease 11.5 129.6 10.7
6. Ischaemic heart disease 13.2 168.4 15.6 Osteoarthritis 0.2 1.2 129.9
7. COPD 13.5 124.8 58.6 Traffic accidents 5.1 115.4 10.8
8. Diabetes 8.2 101.6 79.3 Liver cancer 8.7 123.9 1.7
9. Cirrhosis 8.2 140.5 4.3 Deafness - - 110.7
10. Depression - - 136.9 Anaemia 0.0 0.2 109.3
11. Bronchus & Lung cancer 8.4 109.6 1.5 COPD 5.5 53.2 55.4
12. Homicide and violence 4.1 94.5 13.6 Anxiety disorders - - 104.8
13. Deafness - - 108.1 Asthma 1.1 15.2 78.7
14. Suicides 4.9 105.7 0.9 Lower respiratory tract
infections
6.7 88.8 4.8
15. Lower respiratory tract
infections
6.6 99.7 5.3 Dementia 1.7 12.0 70.8
16. Tuberculosis 5.8 77.2 10.4 Cataracts - - 81.6
17. Asthma 0.8 11.2 76.1 Cervix uteri cancer 4.5 74.0 1.9
18. Osteoarthritis 0.1 0.4 85.6 Nephritis & nephrosis 5.7 71.7 2.9
19. Anaemia 0.0 0.4 84.3 Breast cancer 3.2 59.5 2.6
20. Drownings 3.2 79.0 0.2 Cirrhosis 3.5 55.4 0.9
All causes 235.3 3948.8 1736.9 All causes 176.4 2592.9 1576.1
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percent change in men, 8% than women, 5%. The
leading cause of burden in 2004 was attributed to
HIV/AIDS and stroke in men and women respec-
tively. With the exception of HIV/AIDS and traffic
injuries, other causes in the top ten lists are non-
communicable groups for both men and women. This
clearly shows double burden [31] pattern whereby
chronic diseases burden had a larger share with
increasing trend in the last five years while HIV/AIDS
and traffic injuries remained high burden.
Pattern of disease burden in this study reaffirms Hill
et al [32] findings of epidemiological transition but
interrupted by the 1990s HIV/AIDS epidemic. A projec-
tion of HIV/AIDS [33] when no universal ARV was
assumed shows HIV/AIDS deaths peaked in 2000 and
continued to decline thereafter due to success in pre-
vention. Access to ARV started in 2001 and extended to
cover about 50,000 persons in 2004 [34]; current esti-
mate of 190,000 persons were enrolled in 2009. ART
further reduced HIV mortality.
A p a r tf r o mH I V / A I D S ,o t h e rn o n - d e g e n e r a t i v ed i s -
eases that showed an increased burden were alcohol
dependence/abuse and traffic injuries which warrant
immediate policy attentions. Although drug depen-
dence/abuse considerable declined in 2004, alcohol
dependence/abuse showed a reverse trend. This was
considered as repercussion from a national policy of war
on drug, leading to undisclosed of drug use as well as
substitution between injection drug, methamphetamine
and alcohol [35,36].
COD is one of a major challenge in BOD estimates.
Although completeness of death registration is as high
as 95%, ill-defined COD in vital registration have been
relatively high, about 40% of total deaths in the past
years [21,37]. When the 1999 BOD study was underta-
ken, considerable effort was given to the verbal autopsy
study in producing correcting factors for adjustments.
While the VA study of 2005 had not been available, we
adjusted COD based on the 1999 VA.
Adjusting mortality causes lends itself to the accuracy
of VA study. Due to detail classification of disease
Table 2 Twenty leading causes of DALY (thousands), Thai men, 1999 and 2004
1999 2004
ranks Diseases DALYs % of total DALY rates YLLs/DALYs DALYs % of total DALY rates YLLs/DALYs
1 HIV/AIDS 960 17.2 32.3 0.98 652 11.5 21.1 0.97
2 Traffic accidents 511 9.2 17.2 0.93 591 10.4 19.1 0.93
3 Stroke 268 4.8 9.0 0.89 337 5.9 10.9 0.84
4 Alcohol dependence/harmful use 131 2.3 4.4 0.18 333 5.9 10.8 0.05
5 Liver cancer 248 4.4 8.3 0.99 280 4.9 9.1 0.99
6 Ischaemic heart disease 164 2.9 5.5 0.94 184 3.2 5.9 0.91
7 COPD 157 2.8 5.3 0.71 183 3.2 5.9 0.68
8 Diabetes 168 3.0 5.7 0.54 181 3.2 5.8 0.56
9 Cirrhosis 118 2.1 4.0 0.97 145 2.5 4.7 0.97
10 Depression 96 1.7 3.2 0.00 137 2.4 4.4 0.00
11 Bronchus & Lung cancer 106 1.9 3.6 0.98 111 2.0 3.6 0.99
12 Homicide and violence 156 2.8 5.3 0.98 108 1.9 3.5 0.87
13 Deafness 94 1.7 3.1 0.00 108 1.9 3.5 0.00
14 Suicides 148 2.7 5.0 1.00 107 1.9 3.4 0.99
15 Lower respiratory tract infections 83 1.5 2.8 0.86 105 1.8 3.4 0.95
16 Tuberculosis 94 1.7 3.1 0.91 88 1.5 2.8 0.88
17 Asthma 49 0.9 1.7 0.24 87 1.5 2.8 0.13
18 Osteoarthritis 94 1.7 3.2 0.00 86 1.5 2.8 0.00
19 Anaemia 88 1.6 2.9 0.01 85 1.5 2.7 0.00
20 Drownings 99 1.8 3.3 1.00 79 1.4 2.6 1.00
Group I 1622 29.1 54.5 0.89 1241 21.8 40.1 0.85
Group II 2925 52.4 98.3 0.61 3379 59.4 109.2 0.57
Group III 1034 18.5 34.8 0.93 1066 18.7 34.5 0.90
All causes 5581 100 187.6 0.75 5685 100 183.8 0.69
Note * DALY rate per 1,000 population.
Group I: infectious diseases, maternal, peri-natal and nutritional disorders.
Group II: non-communicable diseases.
Group III: injuries.
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study had a very few number of deaths; uncertainty of
VA results depends on the size of deaths found in each
category. In addition, applying correcting factors from
the 1999 VA to 2004 vital registration relies on an
assumption that pattern of mis-classification in 2004
remained unchanged from that of 1999.
Other limitations are the extensive demand for mor-
tality and epidemiological data which are at times lack-
ing in developing countries [17,38]; also limited
institutional capacities to generate BOD and update on
a regular basis. In terms of national health policy uses,
limitations included poor understanding of the metho-
dology, low involvement of stakeholders, inability of the
methodology to capture key non-economic issues and
the costs of carrying out the study [39].
Another setback of estimating BOD trends is the lack
of, and inconsistency of data sources between the two
periods. We recognized that undertaking normative
work such as BOD assessment required substantial
financial and time resources, institutional capacity and
long term commitments. This limitation in particular in
developing countries challenges if DALY, a summary
measurement of health gap, is a feasible tool for policy
decisions and prioritization [3].
While the GBD is useful in providing burden esti-
mates at regional, groups of countries by development
and income level, and sometimes down to national level;
our results have shown fairly different figures due to dif-
ferent approaches in the estimations and data sources.
Regional estimates can also differ from countries in the
region. Pattern of BOD in Thailand differed from the
SEA Regional estimate but was more close to countries
in the EAP region. We recognise the importance for
countries to build their own capacity on BOD estimates
and national policy utilities.
In 2004 estimate, lack of information is still unresolved
problems. The estimation of YLD essentially demands
Table 3 Twenty leading causes of DALY (thousands), Thai women, 1999 and 2004
1999 2004
ranks Diseases DALYs,
1999
%o f
total
DALY
rates
YLLs/
DALYs
DALYs,
2004
%o f
total
DALY
rates
YLLs/
DALYs
1 Stroke 281 7.1 9.2 0.91 315 7.6 10.0 0.85
2 HIV/AIDS 373 9.4 12.2 0.92 295 7.1 9.3 0.95
3 Diabetes 267 6.8 8.8 0.62 293 7.0 9.3 0.63
4 Depression 145 3.7 4.8 0.00 192 4.6 6.1 0.00
5 Ischaemic heart disease 110 2.8 3.6 0.94 140 3.4 4.4 0.92
6 Osteoarthritis 118 3.0 3.9 0.00 131 3.1 4.1 0.01
7 Traffic accidents 115 2.9 3.8 0.92 126 3.0 4.0 0.91
8 Liver cancer 118 3.0 3.9 0.99 126 3.0 4.0 0.99
9 Deafness 88 2.2 2.9 0.00 111 2.7 3.5 0.00
10 Anaemia 113 2.9 3.7 0.00 109 2.6 3.5 0.00
11 COPD 93 2.4 3.1 0.60 109 2.6 3.4 0.49
12 Anxiety disorders 67 1.7 2.2 0.00 105 2.5 3.3 0.00
13 Asthma 44 1.1 1.4 0.23 94 2.3 3.0 0.16
14 Lower respiratory tract
infections
85 2.1 2.8 0.88 94 2.2 3.0 0.95
15 Dementia 70 1.8 2.3 0.07 83 2.0 2.6 0.15
16 Cataracts 96 2.4 3.1 0.00 82 2.0 2.6 0.00
17 Cervix uteri cancer 55 1.4 1.8 0.97 76 1.8 2.4 0.97
18 Nephritis & nephrosis 55 1.4 1.8 0.98 75 1.8 2.4 0.96
19 Breast cancer 44 1.1 1.4 0.97 62 1.5 2.0 0.96
20 Cirrhosis 43 1.1 1.4 0.98 56 1.3 1.8 0.98
Group I 1016 25.7 33.3 0.76 854 20.5 27.0 0.76
Group II 2634 66.7 86.3 0.58 3007 72.1 95.2 0.56
Group III 297 7.5 9.7 0.93 308 7.4 9.7 0.89
All causes 3946 100 129.3 0.65 4169 100 132.0 0.62
Note * DALY rate per 1,000 population.
Group I: infectious diseases, maternal, peri-natal and nutritional disorders.
Group II: non-communicable diseases.
Group III: injuries.
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available in developing countries where limited epidemio-
logical studies have been conducted. Even Thailand has
fairly advance infrastructure of both data and health ser-
vice system, there is only a few large scale cohort studies.
Therefore, we reasonably rely on information of nature of
disease and sequel from developed countries. This is not
so difficult for diseases prevalent in developed countries.
For sequel of diseases rarely found in developed countries;
panel of experts is applied in our estimates.
Although there are improvements or changes in the
data available for the 2004 assessment, the observed
changes in BOD profile in 1999 and 2004 are due to
actual change in epidemiology of a certain number of
diseases of which time series data exist. For example,
traffic accidents, cancer, and infectious diseases. Also
substantial changes in epidemiology on HIV/AIDS mor-
tality existed as mortality and also years of life loss due
to opportunistic infections had significantly reduced in
2004 both men and women, after the introduction of
universal ART in 2001. Yet YLD estimates for some dis-
eases suffer from inconsistency of the data sources used
in the two assessments.
As generating BOD estimates requires considerable
resources, it is therefore essential that the results have
an impact on health policy. In Thailand, evidence on
BOD was disseminated to relevant health policy makers,
particularly, the Thai Health Promotion Foundation, and
the MOPH. In the national five year health plan and the
Thai Health Promotion Foundation’s master plan, BOD
was referred to and applied as program priority setting.
A number of milestones in policy development in the
Thai Health Promotion Foundation were observed [40]. In
addition, there were nine national alcohol policies during
2003-2007. In 2007, a national plan to address primary
and secondary prevention of chronic NCD called “Thai-
land Healthy Style Strategic Plan”[41] was formulated as a
result of increased awareness among decision-makers.
Lesson learned
Based on 1999 and 2004 experiences, this study draws a
number of lessons for other developing countries facing
similar difficulties. Table 4 summarised challenges and
achievements in two groups: methodological issues and
institutional capacity to generate evidence and translate
evidence into policy decisions.
Table 4 Summary lessons from conducting 1999 and 2004 BOD, Thailand
Challenges Achievements
1. Methodological
issues
1.1 Inadequacy of
data
Incompleteness of mortality data from routine
vital registration
Direct technique estimation of completeness were applied by using time
series from the Survey of Population Change
Poor quality of COD in vital registration Verbal autopsy and medical record investigation were conducted to verify
COD from vital registration
Unavailability of a number of morbidity and
disability data
Use of regional estimates from literature review and GBD estimates
Information from developed country settings were applied in some
instances Consensus meeting with disease experts
Inconsistency of data sources over time Most datasets maintain consistency
1.2 Adaptation on
methods
Classification of disease was not particular fit
with tropical diseases
Leptospirosis was added but there was no disability weight values in the
GBD
Unavailability of DW Estimation was derived from the close matched conditions
2. Institutional
capacity
2.1 Generating BOD
evidence
Fragmentation of mortality and morbidity data
sources, time consuming to collate datasets
The capacity of the Thai Working Group on BOD hosted by IHPP was
gradually institutionalized
Oversight committee provides continued and invaluable supports
Comprehensive assessment of demographic, epidemiologic, and health
services data on mortality and morbidity
Trust based networking with data owners, data users, and disease experts
Results have been further utilized in cost-effectiveness assessment
National financial commitments and support: the 1999 and 2004 BOD
assessments were local research grants. Technical supports from WHO and
international experts are invaluable.
2.2 Translation BOD
into policy decision
BOD were referenced during national policy formulation process and policy
documents, e.g. the Thai Health Promotion Foundation master plan and its
2006 annual report
Results were applied in prioritizing health investment fostering resources in
primary preventions of chronic NCD, in particular tobacco and alcohol
Awareness and increased investments in road safety and HIV preventions.
Bundhamcharoen et al. BMC Public Health 2011, 11:53
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Page 7 of 9Lessons told us that technical capacity is not too far to
reach; there is always a technical solution to a problem.
The difficulty is the institutionalization of capacity to
generate evidence and translate evidence to policy and
prioritization. Local initiation, local funding, long term
commitment and ownership by all stakeholders are key
determinants of institutionalization of capacities for
BOD assessment.
Conclusion
The study highlights unique pattern of disease burden in
Thailand where non-communicable diseases is increas-
ingly the major disease burden while burden from HIV/
AIDS is still high due to mortality and significant years
of life loss among prime adults. Negligent change on
burden from injuries was observed. Regular assessment
of DALY requires continuing improvement in data
sources particularly on cause of death statistics, and
strengthening of institutional capacity to maintain this
important normative work.
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